← All Sponsors
SPONSOR

Augelux Therapeutics

Total Trials
1
Recruiting
1
Phases
N/A

Augelux Therapeutics is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Retinal Dystrophies, Color Vision Defects, Vision Disorders, Macular Degeneration.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Augelux Therapeutics

How many clinical trials has Augelux Therapeutics sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Augelux Therapeutics, of which 1 are actively recruiting participants. These trials cover conditions including Retinal Dystrophies, Color Vision Defects, Vision Disorders. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Augelux Therapeutics research focus on?
Augelux Therapeutics clinical trials span Retinal Dystrophies, Color Vision Defects, Vision Disorders, Macular Degeneration, Achromatopsia, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Augelux Therapeutics clinical trial?
To participate in a Augelux Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Augelux Therapeutics trials with current recruitment status updated daily.

Clinical Trials by Augelux Therapeutics

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology